Skip to main content
Fig. 5 | BMC Pharmacology and Toxicology

Fig. 5

From: The synergy and mode of action of quercetin plus amoxicillin against amoxicillin-resistant Staphylococcus epidermidis

Fig. 5

Ultrathin sections of log phase ARSE 5038 grown in CAMHB containing: (a) control (drug-free); (b) Amoxicillin (8 μg/mL); (c) Quercetin (128 μg/mL); (d) Amoxicillin (3 μg/mL) plus Quercetin (48 μg/mL) (a, b, d, original magnification, 19500×; c, 17000×, bar, 500 nm; Inset: a, b 38000×; bar, 200 nm, c, d, 34000×; bar, 200 nm)

Back to article page